As assessed by qPCR analysis, BRD4 mRNA was found to be expressed in highly enriched sorted CD34+/CD38+ AML progenitor cells and CD34+/CD38− stem cells (Figure 1A). Here, CD38 is linked to acute myeloid leukemia.